S EEN THROUGH the cold lens of statistics, Joe Biden’s statement on May 18th that he had been diagnosed with prostate cancer ...

The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year survival for men with metastatic hormone-sensitive prostate cancer, according to ...

A Gleason score of 8–10 indicates a highly aggressive prostate cancer that will likely grow quickly. In Australia, 67.9% of ...

A newly identified mutation dramatically raises prostate cancer risk in Ashkenazi Jewish men and may increase sensitivity to ...

A diabetes drug may hold the key to preventing prostate cancer relapse. Scientists discovered that prostate cancer patients ...

Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.